España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
XBiotech
XBIT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$6.66
-0.31
-4.45%
At close: -
$6.66
0
0.00%
After Hours: Nov 15, 4:00 PM EDT
Get Report
Comment
XBiotech (XBIT) Forecast
News
Earnings
XBiotech (XBIT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for XBiotech (NASDAQ:XBIT) Stock
XBiotech Stock (NASDAQ: XBIT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, June 18, 2024
What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday?
Vandana Singh
XBiotech shares are trading higher after the ...
Benzinga Newsdesk
XBiotech Says The Primary Endpoint For The Ph...
Benzinga Newsdesk
XBiotech Shares Results From Randomized Doubl...
Benzinga Newsdesk
Monday, January 22, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Tuesday, September 26, 2023
XBiotech Announces Enrollment Completion Of P...
Benzinga Newsdesk
Tuesday, September 05, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Wednesday, August 30, 2023
XBiotech Announces Enrollment Completion Of Phase II, Placebo Controlled, Multicenter Study For Natrunix In Pancreatic Cancer
Happy Mohamed
Tuesday, August 08, 2023
XBiotech Announces First Patient Begins Novel Natrunix Therapy In Phase II Rheumatoid Arthritis Clinical Trial
Happy Mohamed
Monday, May 22, 2023
Xbiotech Announces FDA Authorizes Phase II St...
Benzinga Newsdesk
Wednesday, May 17, 2023
Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
XBiotech shares are trading higher after the ...
Benzinga Newsdesk
Dow Jumps Over 100 Points; US Housing Starts Rise In April
Lisa Levin
XBiotech Commences Tender Offer To Purchase U...
Benzinga Newsdesk
Monday, April 17, 2023
XBiotech Announces First Subject Enrollment In Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke
Happy Mohamed
Monday, November 28, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Thursday, October 20, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Thursday, October 13, 2022
XBiotech Announces First Patient Enrolled Int...
Benzinga Newsdesk
Thursday, September 22, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, September 20, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, September 19, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Wednesday, August 31, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Monday, August 29, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Monday, August 22, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, August 19, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, August 01, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Thursday, July 14, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, June 21, 2022
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
Vandana Singh
Thursday, June 02, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, May 24, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, May 16, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, May 06, 2022
XBiotech Sponsored Study Titled 'Natrunix Ver...
Benzinga Newsdesk
XBiotech Sponsored Study Titled 'Natrunix or ...
Benzinga Newsdesk
Friday, April 29, 2022
74 Biggest Movers From Yesterday
Lisa Levin
Thursday, April 28, 2022
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Why Are XBiotech Shares Trading Higher Today
Vandana Singh
Xbiotech Announces French National Agency Ap...
Benzinga Newsdesk
Tuesday, April 26, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, April 25, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Thursday, April 21, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Monday, April 18, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Thursday, March 31, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Monday, March 14, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Thursday, March 10, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, February 02, 2022
XBiotech Reports Execution Of Manufacturing D...
Benzinga Newsdesk
Wednesday, January 26, 2022
XBiotech Announces First Patient Enrolled In ...
Benzinga Newsdesk
Thursday, January 13, 2022
Lombard International Assurance S.A. Disclose...
Benzinga Newsdesk
Monday, December 13, 2021
XBiotech Announces FDA's Division Of Rheumato...
Bill Haddad
Thursday, October 28, 2021
XBiotech Highlights Launch Of Novel Candidate...
Benzinga Newsdesk
XBiotech Sponsored Study Titled 'Hutrukin Saf...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
